2022
DOI: 10.1111/all.15393
|View full text |Cite
|
Sign up to set email alerts
|

Monkeypox outbreak in Europe, UK, North America, and Australia: A changing trend of a zoonotic disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
32
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(33 citation statements)
references
References 8 publications
0
32
0
1
Order By: Relevance
“…The recent multinational outbreak of monkeypox cases in Europe around the beginning of May 2022 has revealed a changing epidemiological trend [ 2 ]. As of June 22, 3413 confirmed cases have been reported in fifty countries and the number of cases is still rising [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…The recent multinational outbreak of monkeypox cases in Europe around the beginning of May 2022 has revealed a changing epidemiological trend [ 2 ]. As of June 22, 3413 confirmed cases have been reported in fifty countries and the number of cases is still rising [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…It is important to highlight the effects of lockdown on the health of the population, because due to globalization, we must be on alert in case another global pandemic that requires lockdown occurs. At present, while the COVID-19 pandemic has yet to be resolved, outbreaks of monkeypox have been reported in Spain, North America, Australia, the United Kingdom, and several countries of the European Union, which has put the health authorities on alert to the possibility of a new health crisis caused by a new infection that could cause a new state of lockdown depending on its evolution [ 74 ].…”
Section: Discussionmentioning
confidence: 99%
“…Monkeypox is usually a self-limiting illness, with symptoms recovering within 2 to 4 weeks [19] . However, the disease can be severe in some individuals, such as children, pregnant women, or those who are immunocompromised[ 20 , 21 ].…”
Section: Clinical Manifestationsmentioning
confidence: 99%